EMA Recommends Approval for Alvotech’s Gobivaz Biosimilar
September 22, 2025
Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited, a UK headquartered